Fibroblast growth factor 23 does not directly influence skeletal muscle cell proliferation and differentiation or ex vivo muscle contractility

Skeletal muscle dysfunction accompanies the clinical disorders of chronic kidney disease (CKD) and hereditary hypophosphatemic rickets. In both disorders, fibroblast growth factor 23 (FGF23), a bone-derived hormone regulating phosphate and vitamin D metabolism, becomes chronically elevated. FGF23 ha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Physiol Endocrinol Metab
Main Authors: Avin, Keith G., Vallejo, Julian A., Chen, Neal X., Wang, Kun, Touchberry, Chad D., Brotto, Marco, Dallas, Sarah L., Moe, Sharon M., Wacker, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Physiological Society 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6230710/
https://ncbi.nlm.nih.gov/pubmed/29558205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00343.2017
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados